Stockscreener 앱 받기
10.41
0.77%
0.08
시간 외 거래:
10.42
0.010
+0.10%
전일 마감가:
$10.33
열려 있는:
$10.37
하루 거래량:
413.14K
Relative Volume:
0.56
시가총액:
$364.15M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-3.6915
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
-0.57%
1개월 성능:
-8.04%
6개월 성능:
-30.04%
1년 성능:
+30.61%
1일 변동 폭
$10.25
$10.61
1주일 범위
$10.06
$10.81
52주 변동 폭
$7.83
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.41 | 372.55M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
132.00 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.21 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
384.83 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.10 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.16 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer - BioSpace
First patient dosed in Delcath’s phase 2 trial for colorectal cancer - Investing.com
Heatmap Data Shows High Activity in Delcath Systems Inc. SectorWeekly Profit Summary & Daily Market Momentum Tracking - 선데이타임즈
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2025 Earnings Call Transcript - MSN
Delcath Systems Updates Bylaws for Governance Efficiency - MSN
Are Bears Losing Grip on Delcath Systems Inc.July 2025 Action & Growth-Oriented Investment Plans - sisaissue.com
Analyzing drawdowns of Delcath Systems Inc. with statistical toolsWeekly Gains Summary & Step-by-Step Swing Trade Plans - Newser
What’s next for Delcath Systems Inc. stock priceProduct Launch & Safe Entry Zone Tips - Newser
Delcath Systems Inc. stock chart pattern explained2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
Will Delcath Systems Inc. bounce back from current supportPortfolio Risk Summary & Pattern Based Trade Signal System - Newser
H.C. Wainwright Remains Bullish on Delcath Systems (DCTH) - MSN
Best data tools to analyze Pfizer Inc. stock2025 Key Highlights & Entry Point Confirmation Alerts - Newser
What MACD and RSI say about Delcath Systems Inc.July 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
Visual analytics tools that track Delcath Systems Inc. performanceQuarterly Portfolio Report & AI Enhanced Execution Alerts - Newser
Using fundamentals and technicals on Delcath Systems Inc.Inflation Watch & AI Forecasted Stock Moves - Newser
Is Delcath Systems Inc. reversing from oversold territoryTrade Analysis Report & Proven Capital Preservation Methods - Newser
Key resistance and support levels for Delcath Systems Inc.Market Trend Review & Weekly Hot Stock Watchlists - Newser
Delcath Systems Inc. Stock Performance After Earnings: Historical InsightsWeekly Profit Report & Verified Entry Point Detection - Newser
Using Bollinger Bands to evaluate Delcath Systems Inc.July 2025 Action & Fast Entry and Exit Trade Plans - Newser
What makes Delcath Systems Inc. stock price move sharply2025 Growth vs Value & Free Safe Entry Trade Signal Reports - newsyoung.net
Delcath Systems' Earnings May Not Reflect the Company's True Financial Health - AInvest
Impressive Earnings May Not Tell The Whole Story For Delcath Systems (NASDAQ:DCTH) - Yahoo Finance
Healthcare Analysts Bullish on SI-Bone, Delcath Systems, and Cardiol Therapeutics - AInvest
12 Best Medical Device Stocks to Buy According to Analysts - Insider Monkey
Delcath Systems: Huge Potential But With The Handbrake On For Now (NASDAQ:DCTH) - Seeking Alpha
Is Delcath Systems Inc. Starting a New UptrendROI Boosting Trade Opportunity Calendar Published - beatles.ru
Delcath Systems Q3 EPS Forecast Decreased by HC Wainwright - Defense World
Will a bounce in Delcath Systems Inc. offer an exitDay Trading Setup Forecast with Trend Model - Newser
Why Delcath Systems Inc. stock attracts strong analyst attentionDaily Trade Setup Forecast with Confidence - Newser
Real time scanner hits for Delcath Systems Inc. explainedBuy and Hold Position Summary Review - Newser
Intraday pattern recognizer results for Delcath Systems Inc.Free AI Trading Suggestions With Accuracy Focus - Newser
Is Delcath Systems Inc. a turnaround storyBlue Chip Bargain Alerts - thegnnews.com
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $31.00 - Defense World
Analysts Set Expectations for Delcath Systems Q1 Earnings - Defense World
Delcath Systems (NASDAQ:DCTH) Rating Lowered to “Hold” at Wall Street Zen - Defense World
Delcath outlines 175% projected HEPZATO volume growth and targets up to 28 operational centers by year-end 2025 amid expanding clinical pipeline - MSN
Delcath Systems, Inc. Just Recorded A 200% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Delcath Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - uk.finance.yahoo.com
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates - MSN
Delcath Systems Reports Strong Q2 2025 Results - The Globe and Mail
Delcath Systems Reports Strong Q2 Growth Amid Challenges - The Globe and Mail
Delcath’s Revenue Jumps As Cancer Kit Sales Climb - Finimize
Delcath Systems 2025 Q2 Earnings Strong Performance as Net Income Surges 119.6% - AInvest
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Raises Target Price to $31 - 富途牛牛
Delcath Systems’ HEPZATO Drives Strong Growth and Expansion, Justifying Buy Rating - TipRanks
Delcath Systems (DCTH) Sees Analyst Target Price Raised by HC Wa - GuruFocus
We Like These Underlying Return On Capital Trends At Delcath Systems (NASDAQ:DCTH) - uk.finance.yahoo.com
Delcath Systems Reports Second Quarter 2025 Results and Business Highlights - BioSpace
Delcath Systems shares rise 4.23% premarket after reporting Q2 earnings beat and revenue growth. - AInvest
Delcath (DCTH) Q2 Revenue Jumps 210% - AOL.com
Delcath Systems shares rise 4.14% after-hours after reporting Q2 earnings beat and net income of USD 2.7 million. - AInvest
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Delcath Systems Inc 주식 (DCTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Oct 22 '24 |
Option Exercise |
6.00 |
16,666 |
99,996 |
319,334 |
1.55%
자본화:
|
볼륨(24시간):